Paul Goldberg spoke with Samuel Waksal.
When cervical cancer patients were referred to MD Anderson Cancer Center for a prospective, phase III trial testing for noninferiority of minimally invasive vs. open abdominal radical hysterectomy, many requested the minimally invasive approach, because their referring physicians said it was better, said Pedro Ramirez, a professor of gynecologic oncology at MD Anderson.
Gynecologic oncologists need to reduce oncologic risk, but it's not going to happen without knowing why minimally invasive radical hysterectomies decrease survival of patients with cervical cancer, said Joshua Kesterson, chief of the Division of Gynecologic Oncology at Penn State Cancer Institute.
Matthew Ong spoke with Larissa Korde.
A year after starting his job as NCI director, Ned Sharpless is reviewing the entire spectrum of NCI research in an effort to focus on areas where the institute plays a key role.
How do you begin a quest to cure 60 percent of children with six common types of childhood cancer worldwide by 2030?
The $15 million collaboration between St. Jude Children's Research Hospital and the World Health Organization is the first step to improving access in low and middle-income countries to affordable treatments for six common types of childhood cancer, said James Downing, St. Jude president and CEO.
As the new president of the Association of American Cancer Institutes, Roy Jensen will focus on public policy at the state and local level as his presidential priority.
Anne-Marie Langevin, of the South Texas Pediatric Minority/Underserved NCI Community Oncology Research Program site in San Antonio, won the 2018 Harry Hynes Award, which is given annually to the PI who reflects the outstanding contribution to clinical trials and community research.
Matthew Ong spoke with Richard Goldberg.
